The pharmacodynamic effect of amoxycillin and danofloxacin against Actinobacillus pleuropneumoniae in an in-vitro pharmacodynamic model

Research in Veterinary Science

Volumn 67, Issue 1, 1999, Pages 93-97

  Lindecrona, R H ^a,b   Friis, C ^a   Jensen, N E ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; DANOFLOXACIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; DRUG HALF LIFE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TIME;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0032774681     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1053/rvsc.1999.0307     Document Type: Article

References (25)

1. AGERSØ H. & FRIIS C. (1998a) Penetration of amoxycillin into the respiratory tract tissues and secretions in pigs. Research in Veterinary Science, 64, 245-250.
2. AGERSØ H. & FRIIS C. (1998b) Bioavailability of amoxycillin in pigs. Journal of Veterinary Pharmacology and Therapeutics, 21, 41-46.
3. BLASER J., STONE B.B., GRONER M.C. & ZINNER S.H. (1987) Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrobial Agents and Chemotherapy, 31, 1054-1060.
4. BLASER J. & ZINNER S.H. (1987). In vitro models for the study of antibiotic activities. Progress in Drug Research, 31, 349-381.
5. CHAMBERS S.T., PEDDIE B.A., ROBSON R.A., BEGG E.J. & BOSWELL D.R. (1991) Antimicrobial effects of lomefloxacin in vitro. Journal of Antimicrobial Chemotherapy, 27, 481-489.
6. CRAIG W.A. & EBERT S.C. (1992). Continuous infusion of beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy, 36, 2577-2583.
7. DRUSANO G.L. (1991) Human pharmacodynamics of beta-lactams, aminoglycosides and their combination. Scandinavian Journal of Infections Disease, Suppl. 74, 235-248.
8. DRUSANO G.L., JOHNSON D.E., ROSEN M. & STANDIFORD H.C. (1993) Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy, 37, 483-490.
9. DUDLEY M.N., BLASER J., GILBERT D., MAYER K.H. & ZINNER S.H. (1991) Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas Aeruginosa: Effect of simultaneous versus staggered administration in an in vitro model of infection. Journal of Infections Disease, 164, 499-506.
10. FRIIS C. (1993) Penetration of danofloxacin into the respiratory tract tissue and secretions in calves. American Journal of Veterinary Research, 54, 1122-1127.
11. FRIIS C. & NIELSEN J.P. (1997) Penetration of danofloxacin into the respiratory tract tissues and secretions in healthy and in Actinobacillus pleuropneumoniae infected pigs. Proceedings of the 7th EAVPT Congress, Madrid, Spain. Journal of Veterinary Pharmacology and Therapeutics, 20, suppl. 1, 108-109.
12. GIBALDI M. & PERRRIER D. (1982) Pharmacokinetics, 2nd ed. Pp. 409-417. Marcel Dekker, Inc., New York.
13. GRASSO S., MEINARDI G., DE CARNERI I. & TAMASSIA V. (1978) New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity. Antimicrobial Agents and Chemotherapy, 13, 570-576.
14. HAAG R., LEXA P. & WERKHÄUSER I. (1986) Artifacts in dilution pharmacokinetic models caused by adherent bacteria. Antimicrobrial Agents and Chemotherapy, 29, 765-768.
15. JACOBSEN M.J. & NIELSEN J.P. (1995) Development and evaluation of a selective and indicative medium for isolation of Actinobacillus pleuropneumoniae from tonsils. Veterinary Microbiology, 47, 191-197.
16. KNUDSEN J.D., FRIMODT-MØLLER N. & ESPERSEN F. (1995) Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with vatious susceptibilities to penicillin. Antimicrobial Agents and Chemotherapy, 39, 1253-1258.
17. LEGGETT J.E., EBERT S., FANTIN B. & CRAIG W.A. (1991) Comparative dose-effect elations at seveial dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis. Scandinavian Journal of Infectious Disease, Suppl. 74, 179-184.
18. LISTER P.D., PONG A., CHARTRAND S.A. & SANDERS C.C. (1997) Rationale behind high-dose amoxycillin therapy for acute otitis media due to penicillin-non-susceptible pneumococci: Support from in vitro pharmacodynamic studies. Antimicrobial Agents and Chemotherapy, 41, 1926-1932.
19. MARCHBANKS C.R., MCKIEL J.R., GILBERT D.H., ROBILLARO N.J., PAINTER B., ZINNER S.H. & DUDLEY M.N. (1993) Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection. Antimicrobial Agents and Chemotherapv, 37, 1756-1763.
20. MEINEN J.B., MCCLURE J.T. & ROSIN E. (1995) Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections. American Journal of Veterinary Research, 56, 1219-1224.
21. MOUTON J.W. & DEN HOLLANDER J.G. (1994) Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. Antimicrobial Agents and Chemotherapy, 38, 931-936.
22. NCCLS. (1997) Performance standards for antimicrobial disk and dilution susceptibility lests for bacteria isolated from animals. NCCLS Document M31-P Vol. 1, no. 1.
23. PALMER S.M. & RYBAK M.J. (1996) Pharmacodynamics of once-or twice-daily levofloxacin versus vancomycin, with or without rifampin, a gainst Staphylococcus Aureus in an in vitro model with infected platelet-fibrin clots. Antimicrobial Agents and Chemotherapy, 40, 701-705.
24. RAEMDONCK D.L., TANNER A.C., TOLLING S.T. & MICHENER S.L. (1994) Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurelle multocida and Salmonella choleraesuis isolates from pigs. Veterinary Record, 134, 5-7.
25. WOLFSON J.S. & HOOPER D.C. (1989) Bacterial resistance to qumolones: Mecanisms and clinical importance. Review of infections Disease, 11, 960-968.